Department of Obstetrics, Gynecology, and Reproductive Biology, Division of Reproductive Endocrinology and Infertility, Yale University School of Medicine, New Haven, Connecticut 06511, USA.
Curr Opin Obstet Gynecol. 2013 Jun;25(3):223-8. doi: 10.1097/GCO.0b013e328360e96a.
Germline stem cell research over the last decade has brought into question one of the basic tenets of reproductive biology that women are born with a finite number of oocytes without the potential for renewal. Evidence for the existence of oogonial stem cells in the postnatal ovary has gained momentum, but skepticism remains.
Several research studies claimed that they have identified functional oogonial stem cells in the postnatal ovary of several different species including humans. The scientific community has questioned both the methods and significance of these studies.
Many speculate that germline stem cells could make a significant impact on the treatment of female infertility. However, this field of research is still in its infancy. There is still much to learn about the biology of oogonial stem cells and their potential clinical application. More research is needed before oogonial stem cells can become a viable treatment modality for women with infertility.
过去十年的生殖干细胞研究对女性出生时卵子数量有限且无法更新这一生殖生物学的基本原理提出了质疑。虽然越来越多的证据表明卵原干细胞存在于出生后的卵巢中,但仍存在争议。
一些研究声称,他们已经在包括人类在内的几种不同物种的出生后卵巢中鉴定出了功能性卵原干细胞。科学界对这些研究的方法和意义都提出了质疑。
许多人推测生殖干细胞可能会对女性不孕的治疗产生重大影响。然而,这一研究领域仍处于起步阶段。关于卵原干细胞的生物学及其潜在的临床应用,还有很多需要了解的地方。在卵原干细胞成为治疗不孕女性的可行方法之前,还需要进行更多的研究。